• By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.
In the last 4 hours
AbbVie, J&J and the burgeoning immunology market Investors Chronicle11:49 5-May-21
In the last 7 days
AbbVie CEO Is on Deck as Antitrust Hearings Heat Up Center for Biosimilars15:51 3-May-21
AbbVie: A Money Minting Machine Seeking Alpha05:00 3-May-21
Better Buy for 2021: AbbVie or Merck? The Motley Fool11:59 1-May-21
AbbVie’s Q1 Revenue Growth Outpaces Big Pharma Peers Scrip Pharma Intelligence00:02 1-May-21
AbbVie Rises on Q1 Beats, Raised EPS Guidance The Motley Fool21:31 30-Apr-21
How AbbVie Beat Expectations Again in Q1 The Motley Fool15:45 30-Apr-21
AbbVie reports Q1 revenue surge Capital Com15:04 30-Apr-21
AbbVie: Q1 Earnings Snapshot Lexington Herald-Leader, Kentucky12:57 30-Apr-21
AbbVie Earnings, Revenue Beat in Q1 Investing.com12:47 30-Apr-21
AbbVie Reports First-Quarter 2021 Financial Results AbbVie (Press Release)12:45 30-Apr-21
Chairwoman Maloney Announces Oversight Committee Hearing with AbbVie CEO House Committee on Oversight and Reform19:42 29-Apr-21
AbbVie Remains One of the Best Buys in Its Sector Entrepreneur Magazine17:06 29-Apr-21
2 Undervalued Pharmaceutical Stocks to Buy Now The Motley Fool11:16 29-Apr-21
Capsida Biotherapeutics Debuts with $140 Million of Capital PR Newswire (Press Release)10:19 29-Apr-21
In the last month
Top 10 Drugs Of 2020: #10 Imbruvica Scrip Pharma Intelligence17:12 23-Apr-21
AbbVie challenges J&J with Skyrizi PsA submission Pharmaceutical Technology10:02 20-Apr-21
Drugmakers Accused of Causing Opioid Addiction in Trial The Wall Street Journal22:19 19-Apr-21
A Dividend Aristocrat On Sale: AbbVie Seeking Alpha13:43 15-Apr-21
Should AbbVie Be Worried About Rinvoq? The Motley Fool12:11 14-Apr-21
A Short Delay Is Still Bad News for AbbVie The Motley Fool13:07 13-Apr-21
AbbVie: Buy The Humira Fear And Profit Seeking Alpha16:25 11-Apr-21
4 Green Flags for AbbVie in 2021 The Motley Fool11:38 11-Apr-21
Better Value Stock: AbbVie or Viatris? The Motley Fool11:03 10-Apr-21
What Will JAK Inhibitor Safety Jitters Mean For Drug Sales? Scrip Pharma Intelligence23:15 7-Apr-21
Should You Buy AbbVie in April? The Motley Fool12:26 6-Apr-21
view more headlines
6 May 11:02

Publication filters

Headline Density

Sorry, no headlines or news topics were found. Please try different keywords.